European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 8, Status: Authorised

Submitted by Anonymous (not verified) on 7 August 2026 - 14:56

Human medicines European public assessment report (EPAR): Lacosamide Adroiq, lacosamide, Date of authorisation: 31/05/2023, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised

Submitted by Anonymous (not verified) on 7 August 2026 - 14:55

Human medicines European public assessment report (EPAR): Epysqli, eculizumab, Date of authorisation: 26/05/2023, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 33, Status: Authorised

Submitted by Anonymous (not verified) on 7 August 2026 - 14:40

Human medicines European public assessment report (EPAR): Imvanex, smallpox and monkeypox vaccine (Live Modified Vaccinia Virus Ankara), Date of authorisation: 31/07/2013, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 16, Status: Authorised

Submitted by Anonymous (not verified) on 7 August 2026 - 14:01

Human medicines European public assessment report (EPAR): Scemblix, asciminib, Date of authorisation: 25/08/2022, Revision: 16, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness